Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-03-26 13:20 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Culture & Entertainment, Asia Pacific
--------------------------------------------------------------------
Snippet:
TOKYO, March 26, 2026 /PRNewswire/ -- NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise with the art of hospitality.
--------------------------------------------------------------------